Alan Woolf, MD, MPH
|Hospital Title||Director, Program of Environmental Medicine|
|Academic Title||Associate Professor|
1295 Boylston Street
Boston MA 02118
The goal of Alan Woolf's research is to reduce childhood injuries and exposure to toxic substances. His current projects focus on:
- Childhood poisonings.
- Childhood injuries.
- Adverse outcomes from dietary supplements.
About Alan Woolf
Alan Woolf received his MD from the University of Chicago Pritzker School of Medicine and completed an internship, residency, and postgraduate fellowship at Duke University. He received an MPH from the University of North Carolina at Chapel Hill.
Woolf AD, Garg A, Alpert H, Lesko S. Adolescent workplace toxic exposures: a national study. Archives of Pediatric and Adolescent Medicine 2001; 155: 704-710.
Quang LS, Shannon MW, Woolf AD Desai MC, Maher TJ. 4- methylpyrazole (4-MP, Fomepizole, Antizol) is an antidote in CD-1 mice for the delayed and additive toxicity from ethanol and 1,4-butanediol (1,4-BD) overdose. Life Sciences 2002; 8871: 771-778.
- Palmer ME, Haller C, McKinney PE, Klein-Schwartz W, Tschirgi A, Smolinske SC, Woolf A et al. Adverse events associated with dietary supplements: an observational study. Lancet 2003; 361: 101-06.